1. Home
  2. HUBC vs RLMD Comparison

HUBC vs RLMD Comparison

Compare HUBC & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBC
  • RLMD
  • Stock Information
  • Founded
  • HUBC 2017
  • RLMD 2004
  • Country
  • HUBC Israel
  • RLMD United States
  • Employees
  • HUBC N/A
  • RLMD N/A
  • Industry
  • HUBC
  • RLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUBC
  • RLMD Health Care
  • Exchange
  • HUBC Nasdaq
  • RLMD Nasdaq
  • Market Cap
  • HUBC 21.7M
  • RLMD 22.0M
  • IPO Year
  • HUBC N/A
  • RLMD N/A
  • Fundamental
  • Price
  • HUBC $2.07
  • RLMD $0.67
  • Analyst Decision
  • HUBC
  • RLMD Buy
  • Analyst Count
  • HUBC 0
  • RLMD 3
  • Target Price
  • HUBC N/A
  • RLMD $5.00
  • AVG Volume (30 Days)
  • HUBC 1.3M
  • RLMD 478.7K
  • Earning Date
  • HUBC 05-01-2025
  • RLMD 08-06-2025
  • Dividend Yield
  • HUBC N/A
  • RLMD N/A
  • EPS Growth
  • HUBC N/A
  • RLMD N/A
  • EPS
  • HUBC N/A
  • RLMD N/A
  • Revenue
  • HUBC $29,562,000.00
  • RLMD N/A
  • Revenue This Year
  • HUBC N/A
  • RLMD N/A
  • Revenue Next Year
  • HUBC N/A
  • RLMD N/A
  • P/E Ratio
  • HUBC N/A
  • RLMD N/A
  • Revenue Growth
  • HUBC N/A
  • RLMD N/A
  • 52 Week Low
  • HUBC $1.80
  • RLMD $0.24
  • 52 Week High
  • HUBC $14.00
  • RLMD $4.47
  • Technical
  • Relative Strength Index (RSI)
  • HUBC 41.91
  • RLMD 52.84
  • Support Level
  • HUBC $1.80
  • RLMD $0.67
  • Resistance Level
  • HUBC $2.42
  • RLMD $0.72
  • Average True Range (ATR)
  • HUBC 0.28
  • RLMD 0.08
  • MACD
  • HUBC 0.03
  • RLMD -0.03
  • Stochastic Oscillator
  • HUBC 37.66
  • RLMD 40.29

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: